英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
enacting查看　enacting　在百度字典中的解释百度英翻中〔查看〕
enacting查看　enacting　在Google字典中的解释Google英翻中〔查看〕
enacting查看　enacting　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist . . .
    Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity In this phase 3, multinational, randomized
  • Orforglipron: A Comprehensive Review of an Oral Small . . .
    Orforglipron (LY3502970) is a novel, orally available, nonpeptide glucagon-like peptide-1 receptor agonist (GLP-1 RA) designed to replicate the efficacy of injectable GLP-1 RAs for glycemic control and weight reduction while improving convenience
  • Cardiovascular Statistics in the United States, 2026: JACC . . .
    Cardiovascular disease remains the leading cause of morbidity and mortality in the United States JACC Cardiovascular Statistics 2026 reports the most up-to-date data on cardiovascular health in the United States The report covers major cardiovascular risk factors (hypertension, diabetes, obesity, cholesterol, and cigarette smoking) and conditions that collectively account for most
  • My experience using Tirzepatide with MCAS EDS
    In clinical studies, GLP-1 receptor agonists have been associated with modest reductions in LDL cholesterol and total cholesterol, with more variable effects on triglycerides depending on the specific agent and study population
  • IMPACT OF GLP-1 RECEPTOR AGONISTS ON PSYCHIATRIC SYMPTOMS IN . . .
    This study evaluated the impact of GLP-1 receptor agonist (GLP-1 RA) therapy on psychiatric outcomes in adults with type 2 diabetes mellitus (T2DM) or obesity in an Indian tertiary care setting
  • Continued Treatment With Tirzepatide for Maintenance of . . .
    The aim of the SURMOUNT-4 trial was to investigate the effect of continued treatment with the maximum tolerated dose (ie, 10 or 15 mg) of once-weekly tirzepatide, compared with placebo, on the maintenance of weight reduction following an initial open-label lead-in treatment period in participants with obesity or overweight
  • Beyond the Scale: The BELIEVE Trial, Obesity Treatment, and . . .
    GLP-1 receptor agonists including semaglutide (Ozempic Wegovy, Novo Nordisk) and tirzepatide (Mounjaro, Eli Lilly) have transformed obesity medicine over the past five years, achieving weight
  • Metabolic Syndrome: History, Causes, Symptoms, and Modern . . .
    Statins, developed in the 1980s, have significantly reduced cardiovascular risk by lowering LDL cholesterol levels More recent pharmacological innovations include GLP-1 receptor agonists and SGLT2 inhibitors, which not only improve glycemic control but also promote weight loss and cardiovascular protection
  • A Comprehensive Review on Recent Advancements in Navigating . . .
    GLP-1 receptor agonists and preconception planning: bridging the gap between obesity treatment and reproductive safety, a narrative review Ann Med Surg 2025;87 (12):8597–603





中文字典-英文字典  2005-2009